2012 – INVESTIGACIÓN BÁSICA EN PATOLOGÍA CEREBROVASCULAR. ¿POR DÓNDE VAMOS?

2012 – ENDOTHELIAL PROGENITOR CELSS. A NEW KEY FOR ENDOTHELIAL DYSFUNCTION IN MIGRAINE

2012 – EFFI CACY AND TOLERABILITY OF LASMIDITAN, AN ORAL 5-HT1F RECEPTOR AGONIST, FOR THE ACUTE TREATMENT OF MIGRAINE:

2012 – FAMILIA HEMIPLEGIC MIGRAINE WITH PROLONGED GLOBAL AURA.

2011 – TOLL-LIKE RECEPTORS 2 AND 4 IN ISCHEMIC STROKE.

2010 – ONISAMIDA EN EL TRATAMIENTO PREVENTIVO DE LA MIGRAÑA.

2010 – VASCULAR RETINAL, NEUROIMAGING AND UNTRASONOGRAPHIC MAKERS OF LACUNAR INFARCTS

2010 – ASSOCIATION STUDY OF THE SEROTONINERGIC SYSTEM IN MIGRAINE IN THE SPANISH POPULATION

HEMORRAGIA CEREBRAL-URGENCIAS NEUROLOGICAS.

2009 – STATIN TREATMENT WITHDRAWAL IN ISCHEMIC STROKE

2009 – CEFALEA ATRIBUIDA A TRASTORNOS VASCULARES – TRATADO CEFALEAS.

2008 – STATIN TREATMENT WITHDRAWAL IN ISCHEMIC STROKE.

2007 – MMP-9 IMMUNOREACTIVITY IN ACUTE MIGRAINE

2006- CEFALEA EN RACIMOS CRÓNICA.

2006 – TESTING THE COMBINATION BETA-BLOCKER PLUS TOPIRAMATE IN REFRACTORY MIGRAINE

2005 – BENDING THE RULE OF MONOTHERAPY FOR MIGRAINE PREVENTION?

2005 – HEADACHE IN CEREBRAL HEMORRHAGE IN ASSOCIATED T WITH INFLAMMATORY MARKERS AND HIGHER RESIDUAL CAVITY

2005 – HEADACHE IN CEREBRAL HEMORRHAGE IN ASSOCIATED WITH INFLAMMATORY MARKERS AND HIGHER RESIDUAL CAVITY.

2005 – THE IMPACT MIGRAINE ON PSHYCHOLOGICAL WELL-BEING OF YOUNG WOMEN AND THEIR COMMUNICATION WITH PHYSICIANS ABOUT MIGRAINE: A MULTINATIONAL STUDY

2004 – BLOOD PRESSURE DECREASE DURING THE ACUTE PHASE OF ISCHEMIC STROKE IS ASSOCIATED WITH BRAIN INJURY AND POOR STROKE OUTCOME

2004 – THE CLINICAL-DWI MISMATCH

2004 – EARLY NEUROLOGIC DETERIORATION IN INTRACEREBRAL HEMORRHAGE

2004 – PREVENTING DISTURBING MIGRAINE AURA WITH LAMOTRIGINE: AND OPEN STUDY

2004 – THE IMPACT OF MIGRAINE ON WORK, FAMILY, AND LEISURE AMONG YOUNG WOMEN – A MULTINATIONAL STUDY

2003 – APROXIMACIÓN AL PACIENTE CON ICTUS- EVALUACIÓN GENERAL Y NEUROLÓGICA.

2003 – ALMOTRIPTAN VERSUS RIZATRIPTAN IN PATIENTS WITH MIGRAINE IN SPAIN

2002 – HEADACHE AS A SURROGATE MARKER OF THE MOLECULAR MECHANISMS IMPLICATED IN PROGRESSING STROKE

2002 – CCOMBINED THERAPY FOR MIGRAINE PREVENTION? CLINICAL EXPERIENCE WITH B-BLOCKER PLUS SODIUM VALPROATE IN 52 RESISTANT MIGRAINE PATIENTS

1997 – PSUEDOMIGRAINE WITH TEMPORARY NEUROLOGICAL SYMPTOMS AND LYMPHOCYTIC PLEOCYTOSIS